Convergent Genomics, Inc.
Revolutionizing urologic cancer care through genomics.
South San Francisco, United States · Founded 2016
- Headquarters
- South San Francisco, California
- Employees
- 11–50
- Founded
- 2016
- Business Model
- B2B
- Website
- convergentgenomics.com
About
Convergent Genomics is a genomic diagnostics company developing non-invasive urine-based tests for urologic cancer detection and monitoring. Their flagship product UroAmp uses next-generation sequencing and machine learning to detect urothelial cancer earlier and with greater accuracy than standard imaging. The company serves urologists and oncologists seeking to personalize cancer care through actionable genomic insights.
Summary
Convergent Genomics, Inc. is a Biotech company based in South San Francisco, United States, founded in 2016.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/convergent-genomics-inc"><img src="https://indexed.vc/api/badge/company/convergent-genomics-inc" alt="Convergent Genomics, Inc. on Indexed.vc" width="260" height="76" /></a>